fashion -WSS

fashion

author：entertainment 2025-09-27 12:54:15 - browse：873

Scientists Christina Frey and Paul Negulescu work in a lab at Vertex Pharmaceuticals. -- biotech coverage from STAT — Scientists Christina Frey and Paul Negulescu work in a lab at Vertex Pharmaceuticals in San Diego. Sandy Huffaker for STAT

A pain relief drug developed by Vertex Pharmaceuticals succeeded in late-stage clinical trials, the company announced Tuesday, bringing the biopharma giant a step closer to launching what observers believe could be a potential blockbuster and upending decades of pharma failure in a complicated field.

In a pair of randomized, placebo-controlled Phase 3 trials for patients with pain after a tummy tuck or bunion surgery, the drug showed statistically significant pain reduction compared to placebo, meeting the primary endpoints for these studies and the expectations of market analysts. But the experimental therapy didn’t relieve pain better than a combination of acetaminophen and the opioid hydrocodone, a key secondary endpoint observers had been waiting on. And in the bunionectomy trial, the opioid comparator outperformed VX-548 at soothing pain.

The drug, a small molecule known as VX-548, blocks pain-sensing neurons from signaling the pain without the addictive potential of opioids. It was generally safe, with fewer patients on VX-548 reporting adverse events than those taking the placebo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Digital health funding stays low as a new reality sets in

hotspot

WSS

How are insurers handling Leqembi and related scans?

Healthy food access boosts outcomes in two studies

One Duchenne patient's bittersweet hope for new treatment

Antibody drugs appear effective. Now can we make enough of them?

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

How state and local governments are sidelining science

Wikipedia

fashion

focus

Hepatitis C has a cure — but many Americans still lack access to it

One Duchenne patient's bittersweet hope for new treatment

Walensky prepares to leave CDC — and Congress — behind

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Activists slam private health insurers over coverage restrictions

Publishing genetic code of viruses could cause disaster

Jerome Adams on the need for new antivirals for Covid

China sends large group of warplanes, navy ships towards Taiwan in forceful display

23andMe had bad news about my health. I wish a person had delivered it

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

leisure time

FDA reorg will put new emphasis on investigations, sources say

How state and local governments are sidelining science

Publishing genetic code of viruses could cause disaster

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Medicare’s new pay boost for primary care is angering specialists

UnitedHealth sued over use of algorithm in Medicare Advantage plans

hotspot

hotspot

hotspot

explore